Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Monash Ivf Group Ltd

Healthcare AU MVF

0.64AUD
-0.005(0.78%)

Last update at 2026-03-11T05:10:00Z

Day Range

0.630.65
LowHigh

52 Week Range

0.531.17
LowHigh

Fundamentals

  • Previous Close 0.65
  • Market Cap259.11M
  • Volume436320
  • P/E Ratio16.63
  • Dividend Yield1.85%
  • EBITDA45.79M
  • Revenue TTM269.39M
  • Revenue Per Share TTM0.69
  • Gross Profit TTM 84.22M
  • Diluted EPS TTM0.04

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 36.12M -10.65600M 29.84M 26.22M 35.94M
Minority interest - -0.57800M -0.12700M -0.09600M 2.26M
Net income 25.01M -6.52700M 21.84M 18.41M 25.15M
Selling general administrative 15.76M 88.82M 74.13M 66.88M 55.77M
Selling and marketing expenses 8.06M 7.72M 6.92M 6.43M 6.39M
Gross profit 90.31M 85.50M 191.19M 172.51M 163.71M
Reconciled depreciation - 18.58M 15.34M 14.79M 12.89M
Ebit 44.17M -7.79800M 31.07M 26.65M 37.01M
Ebitda 53.01M 10.78M 46.41M 41.44M 49.90M
Depreciation and amortization 8.84M 18.58M 15.34M 14.79M 12.89M
Non operating income net other - - - - -
Operating income 43.41M -5.60900M 35.00M 28.37M 33.59M
Other operating expenses 228.50M 260.57M 101.04M 87.70M 89.46M
Interest expense 7.39M 5.37M 1.23M 0.43M 1.07M
Tax provision 10.45M -4.70700M 7.87M 7.72M 10.44M
Interest income 7.29M 0.06M 0.03M 0.00400M 0.00100M
Net interest income - -5.31200M -3.27900M -2.14700M -1.06500M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 10.45M -4.70700M 7.87M 7.72M 10.44M
Total revenue 271.92M 254.96M 213.59M 192.29M 183.60M
Total operating expenses 46.90M 91.11M 158.07M 144.14M 125.32M
Cost of revenue 181.60M 169.46M 22.40M 19.79M 19.89M
Total other income expense net -7.28900M -5.04700M -5.15757M -2.14700M 2.61M
Discontinued operations - - - - -
Net income from continuing ops - -5.94900M 21.97M 18.50M 25.50M
Net income applicable to common shares 25.01M -6.52700M 21.84M 18.41M 25.15M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 492.61M 508.47M 421.89M 380.82M 351.17M
Intangible assets 23.88M - 25.32M 25.72M 26.81M
Earning assets - - - - -
Other current assets 15.34M 5.68M 4.98M 4.06M 2.94M
Total liab 242.19M 261.81M 146.82M 110.92M 82.23M
Total stockholder equity 246.28M 241.91M 273.20M 267.92M 266.68M
Deferred long term liab - - - - -
Other current liab 45.89M 30.44M 5.71M 0.48M 1.21M
Common stock 506.79M 506.79M 506.79M 506.79M 506.79M
Capital stock - - 506.79M 506.79M 506.79M
Retained earnings -117.14100M -162.73500M -162.73500M -162.73500M -162.73500M
Other liab - - 6.61M 2.65M 2.64M
Good will 273.35M 273.35M 255.13M 233.17M 233.17M
Other assets - - 0.68M 0.17M 0.46M
Cash 9.43M 11.33M 8.01M 7.87M 8.76M
Cash and equivalents - - 1.44M 0.97M 1.75M
Total current liabilities 61.41M 118.82M 46.50M 38.17M 41.08M
Current deferred revenue - 77.32M 32.61M 27.22M 30.16M
Net debt 170.88M 124.04M 92.03M 69.36M 37.23M
Short term debt 9.75M 7.99M 6.33M 7.13M 7.47M
Short long term debt - - - - 1.63M
Short long term debt total 180.31M 135.37M 100.04M 77.23M 45.99M
Other stockholder equity - -0.00000M -409.40800M -404.71300M -403.06000M
Property plant equipment - - 109.39M 95.06M 67.29M
Total current assets 41.68M 55.78M 29.94M 25.64M 22.50M
Long term investments - - 1.28M 1.05M 0.94M
Net tangible assets - - -7.25100M 9.02M 6.70M
Short term investments - - 0.30M - -
Net receivables 7.91M 30.59M 10.53M 8.45M 6.58M
Long term debt - - 38.87M 9.76M 0.00000M
Inventory 9.00M 8.18M 6.43M 5.25M 4.22M
Accounts payable 5.78M 3.08M 1.85M 3.34M 2.25M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -143.37000M -102.14600M -70.85000M -76.13400M -77.37300M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 6.32M 23.97M 0.47M -355.00500M -327.50500M
Deferred long term asset charges - - - - -
Non current assets total 450.92M 452.69M 391.96M 355.17M 328.67M
Capital lease obligations - - 61.17M 67.47M 44.36M
Long term debt total - - 93.71M 70.10M 38.52M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - -38.80000M -40.50800M -15.16200M -11.28700M
Change to liabilities - - 1.96M 0.68M -1.95800M
Total cashflows from investing activities -17.43100M -38.80000M -40.50800M -15.16200M -11.28700M
Net borrowings - 21.00M 19.82M -0.26300M -25.21900M
Total cash from financing activities 2.67M -10.39100M 1.51M -17.62900M -39.07800M
Change to operating activities - - 1.15M 0.35M 1.47M
Net income 25.01M -6.52700M 21.84M 18.41M 25.33M
Change in cash -1.90600M 3.33M 0.13M -0.88700M -6.31100M
Begin period cash flow 11.33M 8.01M 7.87M 8.76M 15.07M
End period cash flow 9.43M 11.33M 8.01M 7.87M 8.76M
Total cash from operating activities 12.90M 52.52M 39.12M 31.89M 43.98M
Issuance of capital stock - - - - -
Depreciation 22.34M 18.58M 12.88M 12.35M 10.70M
Other cashflows from investing activities -1.95800M -0.85300M -12.71900M -3.39900M -1.25400M
Dividends paid -19.87100M -18.32300M 17.14M 16.75M 13.13M
Change to inventory -0.82500M -1.74800M -1.17600M -1.03700M -0.26800M
Change to account receivables 15.44M -20.57000M -2.98400M -2.70200M 0.64M
Sale purchase of stock - - - - -
Other cashflows from financing activities -4.01700M -13.06800M 31.65M 17.25M -8.29400M
Change to netincome - - 3.13M 4.07M 2.23M
Capital expenditures 12.43M 20.82M 27.79M 11.76M 10.03M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 15.60M -20.99500M -4.16000M -3.73900M 0.37M
Stock based compensation 0.77M 0.32M 0.32M 0.25M 0.11M
Other non cash items -50.81700M 61.46M 4.40M 1.13M 7.95M
Free cash flow 0.47M 31.70M 11.33M 20.13M 33.95M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
MVF
Monash Ivf Group Ltd		 -0.005 0.78% 0.64 16.63 13.23 0.96 1.04 1.68 8.89
SHL
Sonic Healthcare Ltd		 -0.41 1.87% 21.51 20.90 17.33 1.10 1.36 1.64 9.70
IDX
Integral Diagnostics Ltd		 -0.01 0.42% 2.36 59.50 16.21 1.16 1.34 1.92 12.30
HLS
Healius Ltd		 -0.02 3.15% 0.61 - 28.01 0.33 0.83 0.99 10.14
ACL
Australian Clinical Labs Ltd		 -0.03 1.37% 2.16 15.86 12.22 0.58 2.80 0.97 3.96

Reports Covered

Stock Research & News

View All

Profile

Monash IVF Group Limited engages in the provision of assisted reproductive and specialist women imaging services in Australia and Malaysia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Richmond, Australia.

Monash Ivf Group Ltd

Pelaco Building 1, Richmond, VIC, Australia, 3121

Key Executives

Name Title Year Born
Mr. Michael D. Knaap CEO, MD & Exec. Director NA
Mr. Malik Jainudeen Group CFO & Company Sec. NA
Dr. Hamish Hamilton Chief Operating Officer NA
Dr. Richard Charles Henshaw M.D. Exec. Director NA
Dr. Deirdre Zander-Fox BSc. (Hons.), Dip. of Mgt, Ph.D. Chief Scientific Officer NA
Mr. Thierry Panthier Chief Information Officer NA
Ms. Fiona Allen Chief Marketing Officer NA
Ms. Peggy North Chief People & Culture Officer NA
Ms. Tedd Fuell Chief Governance & Risk Officer NA
Ms. Clementina Singh Gen. Mang. of New South Wales NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.